|
[1]
|
Springfeld, C., Jäger, D., Büchler, M.W., et al. (2019) Chemotherapy for Pancreatic Cancer. Presse Medicale (Paris, France: 1983), 48, e159-e174. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
高强度聚焦超声肿瘤治疗系统临床应用指南(试行) [J]. 中华医学杂志, 2005(12): 796-797.
|
|
[3]
|
Marinova, M., Wilhelm-Buchstab, T. and Strunk, H. (2019) Advanced Pancreatic Cancer: High-Intensity Focused Ultrasound (HIFU) and Other Local Ablative Therapies. RoFo: Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 191, 216-227. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Yousaf, T., Dervenoulas, G. and Politis, M. (2018) Advances in MRI Methodology. International Review of Neurobiology, 141, 31-76. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
杨欢, 王晓坤, 范金虎. 中国胰腺癌流行病学、危险因素及筛查现况[J]. 肿瘤防治研究, 2021, 48(10): 909-915.
|
|
[6]
|
颜晓一, 谭莉, 吕珂. 经腹超声在介入治疗局部进展期胰腺癌中的应用[J]. 中国介入影像与治疗学, 2021, 18(9): 558-561.
|
|
[7]
|
Tao, S.F., Gu, W.H., Gu, J.C., et al. (2019) A Retrospective Case Series of High-Intensity Focused Ultrasound (HIFU) in Combination with Gemcitabine and Oxaliplatin (Gemox) on Treating El-derly Middle and Advanced Pancreatic Cancer. OncoTargets and Therapy, 12, 9735-9745. [Google Scholar] [CrossRef]
|
|
[8]
|
祝宝让, 刁立岩, 李静, 等. 进展期胰腺癌的高强度聚焦超声消融治疗[J]. 中国超声医学杂志, 2019, 35(9): 817-820.
|
|
[9]
|
Zhu, B., Li, J., Diao, L., et al. (2019) High-Intensity Focused Ultrasound Ablation for Advanced Pancreatic Cancer. Journal of Cancer Research and Therapeutics, 15, 831-835. [Google Scholar] [CrossRef]
|
|
[10]
|
Zhou, Y. (2014) High-Intensity Focused Ultrasound Treatment for Advanced Pancreatic Cancer. Gastroenterology Research and Practice, 2014, Article ID: 205325. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Marchegiani, G. andrianello, S., Malleo, G., et al. (2017) Does Size Matter in Pancreatic Cancer? Reappraisal of Tumour Dimension as a Predictor of Outcome beyond the TNM. Annals of Surgery, 266, 142-148. [Google Scholar] [CrossRef]
|
|
[12]
|
Egawa, S., Toma, H., Ohigashi, H., et al. (2012) Japan Pan-creatic Cancer Registry; 30th Year Anniversary: Japan Pancreas Society. Pancreas, 41, 985-992. [Google Scholar] [CrossRef]
|
|
[13]
|
Lim, J.E., Chien, M.W. and Earle, C.C. (2003) Prognostic Factors Following Curative Resection for Pancreatic Adenocarcinoma: A Population-Based, Linked Database Analysis of 396 Patients. Annals of Surgery, 237, 74-85. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Mitsunaga, S., Hasebe, T., Iwasaki, M., et al. (2005) Important Prognostic Histological Parameters for Patients with Invasive Ductal Carcinoma of the Pancreas. Cancer Sci-ence, 96, 858-865. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Lee, S., Kim, S.H., Park, H.K., et al. (2018) Pancreatic Ductal Adenocarcinoma: Rim Enhancement at MR Imaging Predicts Prognosis after Curative Resection. Radiology, 288, 456-466. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Hattori, Y., Gabata, T., Zen, Y., et al. (2010) Poorly En-hanced Areas of Pancreatic Adenocarcinomas on Late-Phase Dynamic Computed Tomography: Comparison with Patho-logical Findings. Pancreas, 39, 1263-1270. [Google Scholar] [CrossRef]
|
|
[17]
|
Kuhlmann, K.F., De Castro, S.M., Wesseling, J.G., et al. (2004) Surgical Treatment of Pancreatic Adenocarcinoma; Actual Survival and Prognostic Factors in 343 Patients. Euro-pean Journal of Cancer (Oxford, England: 1990), 40, 549-558. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Lüttges, J., Schemm, S., Vogel, I., et al. (2000) The Grade of Pan-creatic Ductal Carcinoma Is an Independent Prognostic Factor and Is Superior to the Immunohistochemical Assessment of Proliferation. The Journal of Pathology, 191, 154-161. [Google Scholar] [CrossRef]
|
|
[19]
|
Rochefort, M.M., Ankeny, J.S., Kadera, B.E., et al. (2013) Impact of Tumor Grade on Pancreatic Cancer Prognosis: Validation of a Novel TNMG Staging System. Annals of Surgical Oncology, 20, 4322-4329. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Kim, J.H., Park, S.H., Yu, E.S., Kim, M.H., et al. (2010) Visually Isoattenuating Pancreatic Adenocarcinoma at Dynamic-Enhanced CT: Frequency, Clinical and Pathologic Characteristics, and Diagnosis at Imaging Examinations. Radiology, 257, 87-96. [Google Scholar] [CrossRef] [PubMed]
|